Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats

Hypertension

Volumn 39, Issue 2 II, 2002, Pages 479-485

  Touyz, Rhian M ^a   Wu, Xiao Hua ^a   He, Gang ^a   Salomon, Steven ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Angiotensin II; Hyperplasia; Kinase; Protein kinases

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ANGIOTENSIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSACTIVATION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; ENZYME ACTIVATION; HYPERTENSION; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SRC-FAMILY KINASES; TRANS-ACTIVATION (GENETICS);

EID: 0036179708     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/hy02t2.102909     Document Type: Conference Paper

References (40)

1. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall
2. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells
3. Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human peripheral resistance arteries: Role of extracellular signal-regulated kinases
4. Characterization of MAP kinase and PKC isoform and effect of ACE inhibition in hypertrophy in vivo
5. Evidence for direct local effect of Ang II in vascular hypertrophy
6. Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats
7. Accelerated entry of aortic smooth muscle cells from spontaneously hypertensive rats into the S phase of the cell cycle
8. 2 angiotensin receptor antagonists in angiotensin II-infused rats
9. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: Effects of angiotensin receptor antagonism and converting enzyme inhibition
10. 1 angiotensin-receptor blockade on structure and function of small arteries in SHR
11. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin II receptor antagonist losartan
12. Blockade of angiotensin II type I receptor: Effect on carotid and radial artery structure and function in hypertensive humans
13. MAP kinases and vascular smooth muscle function
14. Mitogen-activated protein kinase pathways
15. Renal c-fos expression induced by Ang II is enhanced in SHR
16. Induction of immediate-early genes by angiotensin II and endothelin-I in adult rat cardiomyocytes
17. Calcium-dependent EGFR transactivation mediates the Ang II-induced MAP kinase activation in vascular smooth muscle cells
18. Intracellular signaling of Ang II-induced p70 S6 kinase phosphorylation at Ser411 in vascular smooth muscle cells
19. 2+ levels
20. Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance vessels
21. Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates Ang II-mediated signaling and contraction in SHR vascular smooth muscle cells
22. Activation of glomerular MAP kinases in Ang II-mediated hypertension
23. Vascular mitogen-activated protein kinase activity is enhanced via angiotensin system in SHR
24. Induction of mitogen-activated protein kinase phosphatase-I during acute hypertension
25. 2+-dependent MAP kinase activation in SHR vascular smooth muscle defines a hypertensive signal transduction phenotype
26. Cellular functions regulated by Src family kinases
27. c-Src is a major cytosolic tyrosine kinase in vascular tissue
28. The hunting of the Src
29. Activation of extracellular signal-regulated kinases (ERK1/2) by Ang II is dependent on c-Src in vascular smooth muscle cells
30. 2+ signaling by angiotensin II in human vascular smooth muscle cells
31. Discovery of a novel, potent, and Src family -selective tyrosine kinase inhibitor
32. Tyrosine kinase inhibitors, an approach to drug development
33. Dysregulation of Ang II-activated c-Src is an important upstream mediator of enhanced ERK1/2-dependent growth signaling in vascular smooth muscle cells from hypertensive patients
34. Vascular Ang II receptors in SHR
35. 2 receptors in Ang II-stimulated contraction of small mesenteric arteries in young SHR
36. Cell type-specific angiotensin II-evoked signal transduction pathways: Critical roles of Gβγ subunit, Src family, and Ras in cardiac fibroblasts
37. β-arrestin-dependent formation of β2 adrenergic receptor-Src protein kinase complexes
38. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells
39. Effectors for the Rho GTPases
40. Transactivation. A novel signaling pathway from angiotensin II to tyrosine kinase receptors